| Term 
 
        |         Nucleoside Reverse Transcriptase Inhibitors |  | Definition 
 
        | Zidovudine (Retrovir®, AZT) Abacavir (Ziagen®) Tenofovir (Viread®) Emtricitabine (Emtriva®) Zalcitabine (Hivid®) Didanosine (Videx®, ddI) Stavudine (Zerit®, D4T) Lamivudine (Epivir®)   MOA: Inhibits reverse transcriptase; incorporates into viral DNA |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        |         Non-Nucleoside Reverse Transcriptase Inhibitor |  | Definition 
 
        | Etravirine (Intelence®) Efavirenz (Sustiva®) Nevirapine (Viramune®) Delavirdine (Resciptor®)   MOA: Binds to reverse transcriptase and blocks the RNA-dependent and DNA-dependent DNA polymerase activities including HIV-1 replication |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Saquinavir (Invirase®) Indinavir (Crixivan®) Nelfinavir (Viracept®) Ritonavir (Norvir®) Amprenavir (Agenerase®) Lopinavir/Ritonavir (Kaletra®) Foramprenavir (Lexiva®) Atazanavir (Reyataz®) Tipranavir (Aptivus®)   MOA: Binds to the active site of HIV protease and inhibits the activity of this enzyme |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Maraviroc (Selzentry®)     MOA: Binds to human CCR5 receptors, blocking HIV gp120 attachment and preventing cell entry     |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Selzentry®             Entry Inhibitor   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Enfuviritide (Fuzeon®)     
 MOA: Inhibits fusion of virus with host cell membrane, blocking entry and subsequent viral replication |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Raltegravir (Isentress®)       MOA: Inhibits HIV integrase, preventing viral DNA insertion into host cell DNA |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Isentress®             Integrase Inhibitor |  | 
        |  |